These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 35819427)
1. Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder-Reply. Preskorn SH; Risinger R; Kakar R JAMA; 2022 Jul; 328(2):214-215. PubMed ID: 35819427 [No Abstract] [Full Text] [Related]
2. Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder. Abe A; Takeda Y; Ishiki H JAMA; 2022 Jul; 328(2):213. PubMed ID: 35819432 [No Abstract] [Full Text] [Related]
3. Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder. Henry PH; Dantz B JAMA; 2022 Jul; 328(2):213-214. PubMed ID: 35819431 [No Abstract] [Full Text] [Related]
4. Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial. Preskorn SH; Zeller S; Citrome L; Finman J; Goldberg JF; Fava M; Kakar R; De Vivo M; Yocca FD; Risinger R JAMA; 2022 Feb; 327(8):727-736. PubMed ID: 35191924 [TBL] [Abstract][Full Text] [Related]
5. Intranasal Dexmedetomidine Sedation as Adjuvant Therapy in Acute Asthma Exacerbation With Marked Anxiety and Agitation. Cozzi G; Lega S; Giorgi R; Barbi E Ann Emerg Med; 2017 Jan; 69(1):125-127. PubMed ID: 27776827 [TBL] [Abstract][Full Text] [Related]
6. Interventions for the treatment of acute agitation. Citrome L CNS Spectr; 2007 Aug; 12(8 Suppl 11):8-12. PubMed ID: 19317015 [No Abstract] [Full Text] [Related]
7. Use of dexmedetomidine in treatment-refractory post-electroconvulsive therapy agitation. Brydges D; Tibrewal P; Waite S; Dhillon R Aust N Z J Psychiatry; 2016 Apr; 50(4):386-7. PubMed ID: 26508796 [No Abstract] [Full Text] [Related]
8. Cooperative sedation: An option for the management of agitation in moderate traumatic brain injury. Godoy DA; Tolosa K; Lubillo-Montenegro S; Murillo-Cabezas F Med Intensiva; 2017 Apr; 41(3):193-196. PubMed ID: 27085767 [No Abstract] [Full Text] [Related]
9. The treatment of acute agitation associated with schizophrenia or bipolar disorder: investigational drugs in early stages of their clinical development, and their clinical context and potential place in therapy. Ward K; Citrome L Expert Opin Investig Drugs; 2020 Mar; 29(3):245-257. PubMed ID: 32031021 [No Abstract] [Full Text] [Related]
10. Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent. Faden J; Musselman M; Citrome L Expert Rev Neurother; 2023 Feb; 23(2):97-106. PubMed ID: 36707066 [TBL] [Abstract][Full Text] [Related]
11. Benefits of Dexmedetomidine in Management of Post-ECT Agitation. Narang P; Ianovich F; Sarai SK; Lippmann S J ECT; 2017 Sep; 33(3):150-151. PubMed ID: 28178037 [TBL] [Abstract][Full Text] [Related]
12. Old drug in new package promises to calm the agitated. Morrow T Manag Care; 2014 Apr; 23(4):50-1. PubMed ID: 24864536 [No Abstract] [Full Text] [Related]
13. Treatment of Acute Agitation Associated With Excited Catatonia Using Dexmedetomidine: Case Series and Literature Review. Almeida M; Cicolello K; Hanso A; DeCavalcante G; DeOliveira GS Prim Care Companion CNS Disord; 2021 Oct; 23(5):. PubMed ID: 34619813 [No Abstract] [Full Text] [Related]
14. Treatment of post-electroconvulsive therapy agitation with dexmedetomidine. Cohen MB; Stewart JT J ECT; 2013 Jun; 29(2):e23-4. PubMed ID: 23519222 [TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine Infusion may Cause Agitation During Procedural Sedation. Banik S; Rath GP; Huygen FJ Pain Pract; 2016 Jun; 16(5):E89. PubMed ID: 27260117 [No Abstract] [Full Text] [Related]